↓ Skip to main content

Cochrane Database of Systematic Reviews

Agomelatine versus other antidepressive agents for major depression

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs
1 blog
twitter
29 tweeters
facebook
2 Facebook pages
wikipedia
8 Wikipedia pages

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
370 Mendeley
Title
Agomelatine versus other antidepressive agents for major depression
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd008851.pub2
Pubmed ID
Authors

Giuseppe Guaiana, Sumeet Gupta, Debbie Chiodo, Simon JC Davies, Katja Haederle, Markus Koesters

Abstract

Major depressive disorder (MDD), or depression, is a syndrome characterised by a number of behavioural, cognitive and emotional features. It is most commonly associated with a sad or depressed mood, a reduced capacity to feel pleasure, feelings of hopelessness, loss of energy, altered sleep patterns, weight fluctuations, difficulty in concentrating and suicidal ideation. There is a need for more effective and better tolerated antidepressants to combat this condition. Agomelatine was recently added to the list of available antidepressant drugs; it is a novel antidepressant that works on melatonergic (MT1 and MT2), 5-HT 2B and 5-HT2C receptors. Because the mechanism of action is claimed to be novel, it may provide a useful, alternative pharmacological strategy to existing antidepressant drugs.

Twitter Demographics

The data shown below were collected from the profiles of 29 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 370 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
Spain 1 <1%
India 1 <1%
United States 1 <1%
Unknown 365 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 63 17%
Researcher 42 11%
Student > Bachelor 42 11%
Student > Ph. D. Student 34 9%
Student > Doctoral Student 27 7%
Other 70 19%
Unknown 92 25%
Readers by discipline Count As %
Medicine and Dentistry 114 31%
Psychology 40 11%
Nursing and Health Professions 22 6%
Social Sciences 21 6%
Agricultural and Biological Sciences 15 4%
Other 49 13%
Unknown 109 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2022.
All research outputs
#1,177,926
of 22,515,079 outputs
Outputs from Cochrane database of systematic reviews
#2,731
of 12,267 outputs
Outputs of similar age
#12,799
of 273,227 outputs
Outputs of similar age from Cochrane database of systematic reviews
#25
of 132 outputs
Altmetric has tracked 22,515,079 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,267 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.1. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,227 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 132 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.